To examine whether the TGFβ-EMT signature or the NanoString assay-adapted TGFβ-EMTN signature would provide an advantage over these biomarkers, expression levels of EMT and immune biomarkers were correlated with OS and MFS in a lung adenocarcinoma Tissue Microarray (TMA) [34]. This evidence concerns the gene TGFB1 and lung adenocarcinoma.